0001752724-24-124958.txt : 20240529 0001752724-24-124958.hdr.sgml : 20240529 20240529104929 ACCESSION NUMBER: 0001752724-24-124958 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20240328 FILED AS OF DATE: 20240529 DATE AS OF CHANGE: 20240529 PERIOD START: 20240630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Simplify Exchange Traded Funds CENTRAL INDEX KEY: 0001810747 ORGANIZATION NAME: IRS NUMBER: 851887571 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-23570 FILM NUMBER: 24995117 BUSINESS ADDRESS: STREET 1: 222 BROADWAY STREET 2: 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10038 BUSINESS PHONE: 646-741-2438 MAIL ADDRESS: STREET 1: 222 BROADWAY STREET 2: 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10038 0001810747 S000073751 Simplify Health Care ETF C000230898 Simplify Health Care ETF PINK NPORT-P 1 primary_doc.xml NPORT-P false 0001810747 XXXXXXXX S000073751 C000230898 Simplify Exchange Traded Funds 811-23570 0001810747 549300LDDEMEUCZQEO55 222 Broadway 22/F New York 10038 646-741-2438 Simplify Health Care ETF S000073751 549300WPEU6YIKEJVH06 2024-06-30 2024-03-28 N 136164101.19 54592.81 136109508.38 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.01000000 N Bio-Techne Corp 54930073RLKQ51TILZ35 Bio-Techne Corp 09073M104 9152.00000000 NS USD 644209.28000000 0.473302187090 Long EC CORP US N 1 N N N Intuitive Surgical Inc 54930052SRG011710797 Intuitive Surgical Inc 46120E602 32348.00000000 NS USD 12909763.32000000 9.484835757365 Long EC CORP US N 1 N N N Boston Scientific Corp Y6ZDD9FP4P8JSSJMW954 Boston Scientific Corp 101137107 62458.00000000 NS USD 4277748.42000000 3.142872581728 Long EC CORP US N 1 N N N Bristol-Myers Squibb Co HLYYNH7UQUORYSJQCN42 Bristol-Myers Squibb Co 110122108 530.00000000 NS USD 28741.90000000 0.021116746612 Long EC CORP US N 1 N N N Elevance Health Inc 8MYN82XMYQH89CTMTH67 Elevance Health Inc 036752103 5239.00000000 NS USD 2716631.06000000 1.995915709588 Long EC CORP US N 1 N N N Eli Lilly & Co FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co 532457108 8041.00000000 NS USD 6255576.36000000 4.595987770770 Long EC CORP US N 1 N N N Thermo Fisher Scientific Inc HCHV7422L5HDJZCRFL38 Thermo Fisher Scientific Inc 883556102 8271.00000000 NS USD 4807187.91000000 3.531853113875 Long EC CORP US N 1 N N N Abbott Laboratories HQD377W2YR662HK5JX27 Abbott Laboratories 002824100 8467.00000000 NS USD 962359.22000000 0.707047752544 Long EC CORP US N 1 N N N Revvity Inc 549300IKL1SDPFI7N655 Revvity Inc 714046109 25919.00000000 NS USD 2721495.00000000 1.999489258606 Long EC CORP US N 1 N N N Henry Schein Inc VGO3WGL8H45T73F4RR92 Henry Schein Inc 806407102 3520.00000000 NS USD 265830.40000000 0.195306267110 Long EC CORP US N 1 N N N Veralto Corp 635400FJE6GSOJUSNY27 Veralto Corp 92338C103 388.00000000 NS USD 34400.08000000 0.025273825766 Long EC CORP US N 1 N N N Masimo Corp 549300Q4A8JK0PIYCU29 Masimo Corp 574795100 9832.00000000 NS USD 1443829.20000000 1.060784964389 Long EC CORP US N 1 N N N Cooper Cos Inc/The QJKMVPIGLH7530PCUE20 Cooper Cos Inc/The 216648501 62398.00000000 NS USD 6330901.08000000 4.651329033034 Long EC CORP US N 1 N N N Shockwave Medical Inc 549300LDXO56IC5Y1538 Shockwave Medical Inc 82489T104 14945.00000000 NS USD 4866540.35000000 3.575459501633 Long EC CORP US N 1 N N N LivaNova PLC 2138001K2FX6SHK2B339 LivaNova PLC 000000000 8613.00000000 NS USD 481811.22000000 0.353987921736 Long EC CORP GB N 1 N N N Establishment Labs Holdings In 549300BCBQ714JNJ7V58 Establishment Labs Holdings Inc 000000000 25493.00000000 NS USD 1297593.70000000 0.953345372740 Long EC CORP CR N 1 N N N Akero Therapeutics Inc 549300SI3KG74LBE2955 Akero Therapeutics Inc 00973Y108 33199.00000000 NS USD 838606.74000000 0.616126492543 Long EC CORP US N 1 N N N Leap Therapeutics Inc 549300T31SMMJ2DDLI13 Leap Therapeutics Inc 52187K200 375976.00000000 NS USD 1000096.16000000 0.734773177791 Long EC CORP US N 1 N N N Embecta Corp 549300RPG8GXVDHNXZ62 Embecta Corp 29082K105 1399.00000000 NS USD 18564.73000000 0.013639554077 Long EC CORP US N 1 N N N Merck & Co Inc 4YV9Y5M8S0BRK1RP0397 Merck & Co Inc 58933Y105 47663.00000000 NS USD 6289132.85000000 4.620641808830 Long EC CORP US N 1 N N N Zimmer Biomet Holdings Inc 2P2YLDVPES3BXQ1FRB91 Zimmer Biomet Holdings Inc 98956P102 25796.00000000 NS USD 3404556.08000000 2.501335961404 Long EC CORP US N 1 N N N Insulet Corp 549300TZTYD2PYN92D43 Insulet Corp 45784P101 14979.00000000 NS USD 2567400.60000000 1.886275713253 Long EC CORP US N 1 N N N Sarepta Therapeutics Inc 549300IKDPIED8J8IG21 Sarepta Therapeutics Inc 803607100 90523.00000000 NS USD 11719107.58000000 8.610057974261 Long EC CORP US N 1 N N N IDEXX Laboratories Inc OGMTXK0LUU1HKV2P0J84 IDEXX Laboratories Inc 45168D104 2819.00000000 NS USD 1522062.67000000 1.118263292635 Long EC CORP US N 1 N N N PureCycle Technologies Inc N/A PureCycle Technologies Inc 74623V103 1064440.00000000 NS USD 6620816.80000000 4.864330845656 Long EC CORP US N 1 N N N HCA Healthcare Inc 529900PH4ZGUH2MNEU89 HCA Healthcare Inc 40412C101 1415.00000000 NS USD 471944.95000000 0.346739148217 Long EC CORP US N 1 N N N Stryker Corp 5493002F0SC4JTBU5137 Stryker Corp 863667101 5089.00000000 NS USD 1821200.43000000 1.338040561365 Long EC CORP US N 1 N N N Johnson & Johnson 549300G0CFPGEF6X2043 Johnson & Johnson 478160104 24295.00000000 NS USD 3843226.05000000 2.823627897670 Long EC CORP US N 1 N N N Fulcrum Therapeutics Inc N/A Fulcrum Therapeutics Inc 359616109 211031.00000000 NS USD 1992132.64000000 1.463624888305 Long EC CORP US N 1 N N N Exact Sciences Corp 549300VM3X1FYD4N9Z14 Exact Sciences Corp 30063P105 64027.00000000 NS USD 4421704.62000000 3.248637565904 Long EC CORP US N 1 N N N Danaher Corp S4BKK9OTCEWQ3YHPFM11 Danaher Corp 235851102 1253.00000000 NS USD 312899.16000000 0.229887804110 Long EC CORP US N 1 N N N Regeneron Pharmaceuticals Inc 549300RCBFWIRX3HYQ56 Regeneron Pharmaceuticals Inc 75886F107 3050.00000000 NS USD 2935594.50000000 2.156788702670 Long EC CORP US N 1 N N N Royalty Pharma PLC 549300FGFN7VOK8BZR03 Royalty Pharma PLC 000000000 148455.00000000 NS USD 4508578.35000000 3.312463915021 Long EC CORP US N 1 N N N UnitedHealth Group Inc 549300GHBMY8T5GXDE41 UnitedHealth Group Inc 91324P102 1900.00000000 NS USD 939930.00000000 0.690568947891 Long EC CORP US N 1 N N N AbbVie Inc FR5LCKFTG8054YNNRU85 AbbVie Inc 00287Y109 19045.00000000 NS USD 3468094.50000000 2.548017799254 Long EC CORP US N 1 N N N Humana Inc 529900YLDW34GJAO4J06 Humana Inc 444859102 210.00000000 NS USD 72811.20000000 0.053494572764 Long EC CORP US N 1 N N N Tenet Healthcare Corp 0W9AIBT6U6ADJ2I8HK17 Tenet Healthcare Corp 88033G407 4713.00000000 NS USD 495383.43000000 0.363959458744 Long EC CORP US N 1 N N N FIDELITY INV MMTRSY 1 680 N/A FIDELITY INV MMTRSY 1 680 000000000 2590731.98000000 NS USD 2590731.98000000 1.903417337139 Long EC CORP US N 1 N N N Ultragenyx Pharmaceutical Inc 529900EV44GVDN1DCX77 Ultragenyx Pharmaceutical Inc 90400D108 30753.00000000 NS USD 1435857.57000000 1.054928187670 Long EC CORP US N 1 N N N Avantor Inc N/A Avantor Inc 05352A100 109781.00000000 NS USD 2807100.17000000 2.062383593483 Long EC CORP US N 1 N N N Natera Inc N/A Natera Inc 632307104 12669.00000000 NS USD 1158706.74000000 0.851304772011 Long EC CORP US N 1 N N N 3M Co LUZQVYP4VS22CLWDAR65 3M Co 88579Y101 24530.00000000 NS USD 2601897.10000000 1.911620379037 Long EC CORP US N 1 N N N Align Technology Inc 549300N5YSE0U3LCP840 Align Technology Inc 016255101 19251.00000000 NS USD 6312787.92000000 4.638021248578 Long EC CORP US N 1 N N N Syndax Pharmaceuticals Inc 529900OF94TRHKZVBS87 Syndax Pharmaceuticals Inc 87164F105 25337.00000000 NS USD 603020.60000000 0.443040759736 Long EC CORP US N 1 N N N Veeva Systems Inc 549300YZEXPDB92M2F02 Veeva Systems Inc 922475108 1936.00000000 NS USD 448551.84000000 0.329552171144 Long EC CORP US N 1 N N N Cigna Group/The 549300VIWYMSIGT1U456 Cigna Group/The 125523100 24287.00000000 NS USD 8820795.53000000 6.480660781885 Long EC CORP US N 1 N N N 2024-05-24 Simplify Exchange Traded Funds Paul Kim Paul Kim Trustee, President and Treasurer XXXX NPORT-EX 2 469133SIMPLIFY033124.htm
Simplify
Health
Care
ETF
Schedule
of
Investments
March
31,
2024
(Unaudited)
1
Shares
Value
Common
Stocks
–
98.1%
Health
Care
–
91.3%
Abbott
Laboratories
........................................................
8,467
$
962,359‌
AbbVie,
Inc.
..............................................................
19,045
3,468,094‌
Akero
Therapeutics,
Inc.*
...................................................
33,199
838,607‌
Align
Technology,
Inc.*
.....................................................
19,251
6,312,788‌
Avantor
Inc*
..............................................................
109,781
2,807,100‌
Bio-Techne
Corp.
.........................................................
9,152
644,209‌
Boston
Scientific
Corp.*
....................................................
62,458
4,277,748‌
Bristol-Myers
Squibb
Co.
...................................................
530
28,742‌
Cigna
Group
(The)
........................................................
24,287
8,820,796‌
Cooper
Cos.,
Inc.
(The)
.....................................................
62,398
6,330,901‌
Danaher
Corp.
............................................................
1,253
312,899‌
Elevance
Health,
Inc.
......................................................
5,239
2,716,631‌
Eli
Lilly
&
Co.
.............................................................
8,041
6,255,576‌
Embecta
Corp.
...........................................................
1,399
18,565‌
Establishment
Labs
Holdings,
Inc.*
...........................................
25,493
1,297,594‌
Exact
Sciences
Corp*
......................................................
64,027
4,421,705‌
Fulcrum
Therapeutics,
Inc.*
.................................................
211,031
1,992,133‌
HCA
Healthcare
Inc
........................................................
1,415
471,945‌
Henry
Schein,
Inc.*
........................................................
3,520
265,830‌
Humana,
Inc.
.............................................................
210
72,811‌
IDEXX
Laboratories,
Inc.*
...................................................
2,819
1,522,063‌
Insulet
Corp.*
.............................................................
14,979
2,567,401‌
Intuitive
Surgical,
Inc.*
......................................................
32,348
12,909,763‌
Johnson
&
Johnson
........................................................
24,295
3,843,226‌
Leap
Therapeutics,
Inc.*
....................................................
375,976
1,000,096‌
LivaNova
PLC*
...........................................................
8,613
481,811‌
Masimo
Corp.*
...........................................................
9,832
1,443,829‌
Merck
&
Co.,
Inc.
..........................................................
47,663
6,289,133‌
Natera,
Inc.*
.............................................................
12,669
1,158,707‌
Regeneron
Pharmaceuticals,
Inc.*
............................................
3,050
2,935,595‌
Revvity
Inc
...............................................................
25,919
2,721,495‌
Royalty
Pharma
PLC,
Class
A
...............................................
148,455
4,508,578‌
Sarepta
Therapeutics
Inc*
...................................................
90,523
11,719,108‌
Shockwave
Medical,
Inc.*
...................................................
14,945
4,866,540‌
Stryker
Corp.
.............................................................
5,089
1,821,200‌
Syndax
Pharmaceuticals,
Inc.*
...............................................
25,337
603,021‌
Tenet
Healthcare
Corp.*
....................................................
4,713
495,383‌
Thermo
Fisher
Scientific,
Inc.
................................................
8,271
4,807,188‌
Ultragenyx
Pharmaceutical
Inc*
..............................................
30,753
1,435,858‌
UnitedHealth
Group,
Inc.
....................................................
1,900
939,930‌
Veeva
Systems,
Inc.,
Class
A*
...............................................
1,936
448,552‌
Zimmer
Biomet
Holdings
Inc
.................................................
25,796
3,404,556‌
124,240,066‌
Industrials
–
1.9%
3M
Co
..................................................................
24,530
2,601,897‌
Veralto
Corp.
.............................................................
388
34,400‌
2,636,297‌
Simplify
Health
Care
ETF
Schedule
of
Investments
(Continued)
March
31,
2024
(Unaudited)
2
††
The
percentage
shown
for
each
investment
category
is
the
total
value
of
investments
in
that
category
as
a
percentage
of
the
net
assets
of
the
Fund.
The
table
depicts
the
Fund's
investments
but
may
not
represent
the
Fund's
market
exposure
to
certain
derivatives,
if
any,
which
are
included
in
Other
Assets
in
Excess
of
Liabilities.
Shares
Value
Common
Stocks
(continued)
Materials
–
4.9%
PureCycle
Technologies,
Inc.*
...............................................
1,064,440
$
6,620,817‌
Total
Common
Stocks
(Cost
$120,797,281)
.........................................
133,497,180‌
Money
Market
Funds
–
1.9%
Fidelity
Investments
Money
Market
Treasury
Only
Portfolio
-
Class
I,
5.20%(a)
(Cost
$2,590,732)
.......................................................
2,590,732
2,590,732‌
Total
Investments
–
100.0%
(Cost
$123,388,013)
...........................................................
$
136,087,912‌
Other
Assets
in
Excess
of
Liabilities
–
0.0%†
..........................................
21,596‌
Net
Assets
–
100.0%
............................................................
$
136,109,508‌
*
Non
Income
Producing
†
Less
than
0.05%
(a)
Rate
shown
reflects
the
7-day
yield
as
of
March
31,
2024.
Summary
of
Investment
Type††
Industry
%
of
Net
Assets
Common
Stocks
.................................................................................
98.1‌%
Money
Market
Funds
.............................................................................
1.9‌%
Total
Investments
................................................................................
100.0‌%
Other
Assets
in
Excess
of
Liabilities
..................................................................
0.0‌%†
Net
Assets
.....................................................................................
100.0‌%